Cargando…

A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer

BACKGROUND: and purpose: This retrospective study aimed to investigate the feasibility of shrinking field radiotherapy during chemoradiotherapy in non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Ninety-seven patients with stage III NSCLC who achieved a good response to chemoradiation were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Chenxue, Han, Shuiyun, Chen, Wucheng, Ying, Xiaozhen, Wu, He, Zhu, Yaoyao, Shi, Guodong, Sun, Xiaojiang, Xu, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844760/ https://www.ncbi.nlm.nih.gov/pubmed/29552324 http://dx.doi.org/10.18632/oncotarget.23849

Ejemplares similares

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study
por: Hu, Min, et al.
Publicado: (2020)

Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost
por: Melcher, A A, et al.
Publicado: (2003)

A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma
por: Sun, Xiaojiang, et al.
Publicado: (2016)

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study
por: Horinouchi, Hidehito, et al.
Publicado: (2020)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
por: Sher, David J.
Publicado: (2017)

Shrinking Lung Syndrome in Primary Sjögren Syndrome
por: Uslu, Sadettin, et al.
Publicado: (2020)

The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020)

Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
por: Sun, Xiaojiang, et al.
Publicado: (2020)

Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study
por: Tang, Shi, et al.
Publicado: (2023)

Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
por: Takada, Akinori, et al.
Publicado: (2016)

Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
por: Kang, Ki Mun, et al.
Publicado: (2012)

Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
por: Conibear, John
Publicado: (2020)

To grow or to shrink…
por: LeBrasseur, Nicole
Publicado: (2003)

Shrinking spines
por: Bashyam, Hema
Publicado: (2007)

The shrinking world
por: Kumar, Rajeev
Publicado: (2014)

Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
por: Dang, Jun, et al.
Publicado: (2014)

Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non‐small‐cell lung cancer after definitive chemoradiotherapy
por: Sakaguchi, Tadashi, et al.
Publicado: (2021)

Deinococcus geothermalis: The Pool of Extreme Radiation Resistance Genes Shrinks
por: Makarova, Kira S., et al.
Publicado: (2007)

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2020)

Concurrent Chemoradiotherapy with Vinorelbine plus Split-Dose Cisplatin may be an Option in Inoperable Stage III Non-Small Cell Lung Cancer: A Single-Center Experience
por: Mertsoylu, Hüseyin, et al.
Publicado: (2015)

Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
por: Park, Junhee, et al.
Publicado: (2018)

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
por: Liu, Ming, et al.
Publicado: (2017)

Association between IDO activity and prognosis in patients with non-small cell lung cancer after radiotherapy
por: Zhu, Yaoyao, et al.
Publicado: (2020)

Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis
por: Katsui, Kuniaki, et al.
Publicado: (2021)

Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study
por: Miyawaki, Eriko, et al.
Publicado: (2022)

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
por: Haslett, Kate, et al.
Publicado: (2021)

Isolated Finger Palsy Following a Spectacular Shrinking Deficit
por: Sugiura, Mieko, et al.
Publicado: (2017)

Is the Meyrin site shrinking?
Publicado: (1998)

Death and the shrinking nucleus
por: Dove, Alan W.
Publicado: (2003)

The amazing shrinking laboratory.
por: Medlin, J
Publicado: (1995)

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
por: Zhao, Qun, et al.
Publicado: (2015)

Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022)

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
por: van Rossum, Peter S. N., et al.
Publicado: (2023)

Spontaneously shrinking lung mass due to Mycobacterium avium mimicking lung cancer
por: Kinjo, Takeshi, et al.
Publicado: (2021)

Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
por: Abacioglu, Ufuk, et al.
Publicado: (2005)

The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer
por: Jiang, Chenxue, et al.
Publicado: (2021)

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
por: Chen, Xin-Ru, et al.
Publicado: (2016)

FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer
por: ZHENG, YUANDA, et al.
Publicado: (2014)

Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
por: Han, Shuiyun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ubf9b1r0f4b5alujaktcqdoocc